Paradromics Achieves Real-Time Speech with Connexus® Brain-Computer Interface
AUSTIN, Texas--(BUSINESS WIRE)--Paradromics Inc., a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform designed to restore and enhance human capabilities, today announced that the first participant implanted with the Connexus® BCI has successfully used the system for real-time speech and text communication. The milestone was achieved as part of the Connect-One Early Feasibility Study, conducted under an FDA-approved Investigational Device Exemption (IDE)